These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
77 related items for PubMed ID: 1971568
1. Selective inactivation by chlorofluoroacetamides of the major phenobarbital-inducible form(s) of rat liver cytochrome P-450. Halpert J, Jaw JY, Balfour C, Kaminsky LS. Drug Metab Dispos; 1990; 18(2):168-74. PubMed ID: 1971568 [Abstract] [Full Text] [Related]
2. Selective inactivation of four rat liver microsomal androstenedione hydroxylases by chloramphenicol analogs. Stevens JC, Halpert J. Mol Pharmacol; 1988 Jan; 33(1):103-10. PubMed ID: 3336347 [Abstract] [Full Text] [Related]
3. Inactivation of cytochromes P450 2B protects against cocaine-mediated toxicity in rat liver slices. Poet TS, Brendel K, Halpert JR. Toxicol Appl Pharmacol; 1994 May; 126(1):26-32. PubMed ID: 8184429 [Abstract] [Full Text] [Related]
4. Dichloromethyl compounds as mechanism-based inactivators of rat liver cytochromes P-450 in vitro. Halpert JR, Balfour C, Miller NE, Kaminsky LS. Mol Pharmacol; 1986 Jul; 30(1):19-24. PubMed ID: 3724741 [Abstract] [Full Text] [Related]
5. Mechanism-based inactivation of the major beta-naphthoflavone-inducible isozyme of rat liver cytochrome P-450 by the chloramphenicol analog N-(2-p-nitrophenethyl)dichloroacetamide. Miller NE, Halpert JR. Drug Metab Dispos; 1987 Jul; 15(6):846-51. PubMed ID: 2893712 [Abstract] [Full Text] [Related]
6. Selective inactivation by chloramphenicol of the major phenobarbital-inducible isozyme of dog liver cytochrome P-450. Ciaccio PJ, Duignan DB, Halpert JR. Drug Metab Dispos; 1987 Jul; 15(6):852-6. PubMed ID: 2893713 [Abstract] [Full Text] [Related]
7. Selective inactivation of rat liver cytochromes P-450 by 21-chlorinated steroids. Halpert J, Jaw JY, Cornfield LJ, Balfour C, Mash EA. Drug Metab Dispos; 1989 Jul; 17(1):26-31. PubMed ID: 2566465 [Abstract] [Full Text] [Related]
8. Isozyme selectivity of the inhibition of rat liver cytochromes P-450 by chloramphenicol in vivo. Halpert J, Balfour C, Miller NE, Morgan ET, Dunbar D, Kaminsky LS. Mol Pharmacol; 1985 Sep; 28(3):290-6. PubMed ID: 4033629 [Abstract] [Full Text] [Related]
9. Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase. Ng SF, Waxman DJ. Cancer Res; 1990 Feb 01; 50(3):464-71. PubMed ID: 2105156 [Abstract] [Full Text] [Related]
10. Altered regulation of cytochrome P-450 enzymes in choline-deficient cirrhotic male rat liver: impaired regulation and activity of the male-specific androst-4-ene-3,17-dione 16 alpha-hydroxylase, cytochrome P-450UT-A, in hepatic cirrhosis. Murray M, Zaluzny L, Dannan GA, Guengerich FP, Farrell GC. Mol Pharmacol; 1987 Jan 01; 31(1):117-21. PubMed ID: 3543647 [Abstract] [Full Text] [Related]
11. Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat. Panesar SK, Bandiera SM, Abbott FS. Drug Metab Dispos; 1996 Jun 01; 24(6):619-27. PubMed ID: 8781776 [Abstract] [Full Text] [Related]
12. Colocalized alterations in connexin32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters. Neveu MJ, Babcock KL, Hertzberg EL, Paul DL, Nicholson BJ, Pitot HC. Cancer Res; 1994 Jun 15; 54(12):3145-52. PubMed ID: 8205533 [Abstract] [Full Text] [Related]
13. Induction of rat hepatic cytochrome P450 2B subfamily by azidophenobarbital, as a possible photoaffinity probe for the putative phenobarbital receptor: comparative study with modified phenobarbitals with different functional groups. Shinohara T, Taura Ki, Imamura T, Yamada H, Oguri K. Drug Metab Dispos; 1997 Dec 15; 25(12):1442-6. PubMed ID: 9394036 [Abstract] [Full Text] [Related]
14. Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics. Reidy GF, Mehta I, Murray M. Mol Pharmacol; 1989 May 15; 35(5):736-43. PubMed ID: 2725477 [Abstract] [Full Text] [Related]
15. Induction of microsomal NADPH-cytochrome P-450 reductase and cytochrome P-450IVA1 (P-450LA omega) by dehydroepiandrosterone in rats: a possible peroxisomal proliferator. Wu HQ, Masset-Brown J, Tweedie DJ, Milewich L, Frenkel RA, Martin-Wixtrom C, Estabrook RW, Prough RA. Cancer Res; 1989 May 01; 49(9):2337-43. PubMed ID: 2523237 [Abstract] [Full Text] [Related]
16. Molecular basis for a functionally unique cytochrome P450IIB1 variant. Kedzie KM, Balfour CA, Escobar GY, Grimm SW, He YA, Pepperl DJ, Regan JW, Stevens JC, Halpert JR. J Biol Chem; 1991 Nov 25; 266(33):22515-21. PubMed ID: 1718996 [Abstract] [Full Text] [Related]
17. Effect of ovariectomy and androgen on phenobarbital induction of hepatic CYP2B1 and CYP2B2 in Sprague-Dawley rats. Chang TK, Anderson MD, Bandiera SM, Bellward GD. Drug Metab Dispos; 1997 Aug 25; 25(8):994-1000. PubMed ID: 9280408 [Abstract] [Full Text] [Related]
18. Ring hydroxylation of [o-3H]methoxychlor as a probe for liver microsomal CYP2B activity: potential for in vivo CYP2B assay. Stresser DM, Dehal SS, Kupfer D. Anal Biochem; 1996 Jan 01; 233(1):100-7. PubMed ID: 8789153 [Abstract] [Full Text] [Related]
19. Effect of phenobarbital treatment and cytochrome P-450 inhibitors on the laurate omega- and (omega - 1)-hydroxylase activities of rat liver microsomes. Okita RT, Masters BS. Drug Metab Dispos; 1980 Jan 01; 8(3):147-51. PubMed ID: 6104577 [Abstract] [Full Text] [Related]
20. In vivo and in vitro effects of beta-naphthoflavone on cytochrome P-450-dependent testosterone hydroxylase activities in liver microsomes. Shiverick KT. Drug Metab Dispos; 1981 Jan 01; 9(6):545-50. PubMed ID: 6120814 [Abstract] [Full Text] [Related] Page: [Next] [New Search]